Demand Forecasting

Meeting public-health needs in developing countries is made more difficult without accurate forecasting of the demand for medical products—no matter how much money is available to develop and purchase them. Shortcomings in demand forecasting increase risks for suppliers, resulting in higher costs, supply shortages, and uncertainty surrounding R&D. CGD’s Demand Forecasting initiative led to the publication in 2007 of A Risky Business with recommendations for specific public and private organizations to smooth the delivery of health products to the people who need them.

XSubscribe to Content Alerts.

You will receive alerts via e-mail when new content is added to this page.

(if not affiliated type "individuals")
Share

CGD convened the Global Health Forecasting Working Group to study the challenges surrounding demand forecasting. After a year of research and deliberation and further consultation among a broad set of interested parties, the group concluded that better forecasting requires wider sharing of the risk involved in producing drugs and aligning incentives among those who influence market dynamics through three mutually enforcing actions:

Read the working group's report or policy brief to learn more.

Recent Work